Neogen (NEOG) Operating Margin Growth (5y) (2015 - 2026)
Neogen (NEOG) Operating Margin Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn |
| 10 | Neogen | 2.08 Bn | 1.92 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -1,508.00 |
| Nov 30, 2025 | -1,913.00 |
| Aug 31, 2025 | -590.00 |
| May 31, 2025 | -28,937.00 |
| Feb 28, 2025 | -1,062.00 |
| Nov 30, 2024 | -21,477.00 |
| Aug 31, 2024 | -1,500.00 |
| May 31, 2024 | -1,156.00 |
| Feb 29, 2024 | -973.00 |
| Nov 30, 2023 | -1,074.00 |
| Aug 31, 2023 | -818.00 |
| May 31, 2023 | -868.00 |
| Feb 28, 2023 | -958.00 |
| Nov 30, 2022 | -2,120.00 |
| Aug 31, 2022 | -1,285.00 |
| May 31, 2022 | -635.00 |
| Feb 28, 2022 | -1,443.00 |
| Nov 30, 2021 | -11,295.00 |
| Aug 31, 2021 | -11,237.00 |
| May 31, 2021 | -145.00 |